Table 1.
Placebo (N = 3906) | Denosumab (N = 3902) | |
---|---|---|
Age (years), mean ± SD | 72.3 ± 5.2 | 72.3 ± 5.2 |
Total hip BMD T-score, mean ± SD | –1.91 ± 0.81 | –1.89 ± 0.81 |
Lumbar spine BMD T-score, mean ± SD | –2.84 ± 0.69 | –2.82 ± 0.70 |
Prevalent vertebral fracture, % (n) | 23.4% (915) | 23.8% (929) |
History of nonvertebral fracture in those ≥55 years, % (n) | 30.1% (1177) | 29.8% (1163) |
History of nonvertebral fracture, % (n) | 38.6% (1507) | 39.1% (1524) |